CNC · Centene Corp
Price
Snapshot
50 fields · last close| Market Cap | $34.16B |
| P/E | — |
| Float | 492.0M |
| Beta | 1.08 |
| Volatility | 27.0% |
| Exchange | NYSE |
| Sector | Health Care |
| Cap tier | Large cap |
| Macro sensitivity | Moderate |
| Clavix score | 76.3 |
| Price | 67.65 |
| Change | −2.18% |
| Prev Close | 69.16 |
| Open | 71.19 |
| Day Low | 69.02 |
| Day High | 71.21 |
| Avg Vol | 4 |
| Avg $ Vol | $290.1M |
| 52W High | 71.21 |
| 52W Low | 31.63 |
| 52W Pos | 91.0% |
| From High | −5.00% |
| From Low | +113.88% |
| Max DD 1Y | −32.73% |
| Spread | 0.10% |
| Liquidity | Normal |
| SMA 20 | +4.52% |
| SMA 50 | +3.45% |
| SMA 200 | +24.93% |
| RSI (14) | 62.5 |
| Vol 30D | 32.5% |
| Vol 90D | 35.7% |
| 1Y Range | 32–71 |
| Daily bars | 537 |
| Perf Week | +5.81% |
| Perf Month | +3.07% |
| Perf Quarter | +5.04% |
| Perf Half Y | +80.53% |
| Perf Year | +94.05% |
| Perf YTD | +61.92% |
| Prev Day | −2.18% |
| Clavix | B |
| Debt / Eq | 0.88 |
| Curr Ratio | 1.10 |
| Int Cover | -6.1× |
| FCF Margin | 2.5% |
| Rev Growth | +19.4% |
| Profit | Unprofitable |
| Leverage | Moderate |
| Sector rank | 28 / 49 |
What CNC does
Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States.
It operates through four segments: Medicaid, Medicare, Commercial, and Other. The Medicaid segment offers the temporary assistance for needy families; medicaid expansion; aged, blind, or disabled; and children's health insurance programs, as well as long-term services and supports; foster care; and medicare-medicaid plans.
This segment also provides healthcare products and services. The Medicare segment offers special needs and medicare supplement, and prescription drug plans.
The Commercial segment provides health insurance marketplace product for individual and commercial group.
The Other segment operates clinical healthcare and pharmacies, as well as offers vision and dental, behavioral health, and centralized services.
It provides services through primary and specialty care physicians, hospitals, behavioral health practitioners, and ancillary providers.
The company was founded in 1984 and is headquartered in Saint Louis, Missouri.
Clavix risk grade
regraded every trading dayCNC grades B, 76.3 of 100. Steadiest on Sector Resilience (70), most exposed on News Sentiment (50, mixed). 1 of the 4 weighted dimensions sit above the Health Care median. Ranks 28 of 49 in Health Care by Clavix score.
How rough the ride is
| CNC | Health Care median | |
|---|---|---|
| Betavs the overall market · lower is steadier | 1.08 | 0.84 |
| Volatilityannualized | 27.0% | 20.9% |
| Max drawdown, past yearworst peak-to-trough fall | −32.7% | — |
| Typical daily movemedian absolute daily change | 1.47% | — |
| Days beyond ±3%of the last 252 sessions | 61 (24%) | — |
How its days are spread
Daily returns over the last 252 sessions in 1% bins. Moves beyond ±6% land in the end bins.
52-week range
The bar runs from the lowest to the highest close of the last 252 sessions; the marker is the latest close.
Drawdown from the 1-year peak
Percent below the running high over the last 12 months. Zero is a fresh high.
Market sensitivity
| CNC | Health Care median | |
|---|---|---|
| Beta to the markethow much it swings with the S&P 500 · lower is safer | 1.08 | 0.84 |
| Macro sensitivityrate, dollar and credit exposure bucket | Moderate | Moderate 53% of 49 |
Where it sits on the macro scale
Low means rates, the dollar and credit spreads barely move it. Very High means they drive a large share of its swings. The counts are how many Health Care names sit in each bucket.
Where it ranks in its sector
Rank by Clavix score within the sector. Right is the top of the sector.
Price performance
| CNC | |
|---|---|
| 1 week | +5.8% |
| 1 month | +3.1% |
| Year to date | +61.9% |
| 1 year | +94.1% |
Context for the rank, not itself a risk measure.
Recent coverage, scored
| CNC | |
|---|---|
| Articles scoredthe most recent scored coverage, up to 30 | 30 since 17 Sep |
| Average score0 most bearish, 100 most bullish | 58 |
| Bullish · bearisharticles above 60 · below 40 | 14 · 4 |
| Directionarticles whose tone is improving vs worsening | 14 ↑ 4 ↓ |
Where the article scores land
Each bar is a 10-point band of article scores. Below 40 reads bearish, above 60 bullish.
Balance sheet, against the sector
The shaded band is the middle half of the 49 Health Care names Clavix covers; the tick is the sector median.
Growth
| CNC | |
|---|---|
| Revenue growthyear over year | +19.4% |
Financial Health is shown but does not count toward the grade. Why
0–100, higher is safer. The tick on each bar is the Health Care median. Click a dimension for the evidence behind it. Financial Health is shown but does not count toward the grade.
Recent news
most recent scored articles · the chip is the article’s score · click to openCentene is expanding its CHOICE Arrangements benefits program, a defined-contribution health benefits offering, to its own employees in Ohio and Oklahoma starting in the 2027 plan year.
Centene Corporation announced it will expand its CHOICE Arrangements employee benefit program (formerly called ICHRA) to workers in Ohio and Oklahoma for plan year 2027, building on what the company described as early success with the program in Indiana during 2026.
Centene announced it is expanding its CHOICE Arrangements employee benefit programs into Ohio and Oklahoma for plan year 2027, building on the early rollout in Indiana that began in 2026. CHOICE Arrangements appear to be a type of employer-sponsored health benefit arrangement.
Centene's profitability is bouncing back faster than expected, with Q2 2026 adjusted profit of $2.51 per share reversing a prior-year loss. The company raised its full-year adjusted EPS guidance to above $4.80, helped by stronger margins in its Obamacare-style Marketplace plans and Medicare prescription drug plans, even as Marketplace membership fell 40% year-over-year.
An analyst maintains a Buy rating on Centene heading into Q3, citing expected operational improvements, disciplined capital management, and a discounted valuation versus sector averages. The analyst expects Medicaid margins to hold despite 8-9% membership attrition, aided by favorable rate adjustments and medical cost control, and projects Medicare prescription drug plan margins above 3% for the year, up from 2%.
Nearest peers by size
Health Care| Ticker | Company | Grade | Mkt cap | P/E | Beta | |
|---|---|---|---|---|---|---|
| RMD | Resmed Inc | B+ | $33.61B | 22.06 | 0.77 | Compare |
| DXCM | Dexcom Inc | B | $32.47B | 32.48 | 1.44 | Compare |
| GEHC | GE Healthcare Technologies Inc | B | $31.42B | 15.83 | 0.83 | Compare |
| ALC | Alcon AG | B+ | $27.54B | 40.81 | 1.07 | Compare |
| IDXX | IDEXX Laboratories Inc | B+ | $44.15B | 38.74 | 1.55 | Compare |
| DGX | Quest Diagnostics Inc | A- | $25.94B | 24.42 | 0.56 | Compare |
| LH | Labcorp Holdings Inc | A- | $25.79B | 25.73 | 0.89 | Compare |
| MDLN | Medline Inc | B | $47.28B | 68.22 | 0.95 | Compare |
You just read one holding. Clavix reads the whole portfolio.
Every position you own, graded on the same five dimensions, with an alert when a grade moves. 1 month free on iPhone.